- Search results for antibody
| Image | Title | |
|---|---|---|
 | The older you are, the more antibodies you'll have, finds Montreal researchersIn their study published in Scientific Reports, they observe that those who received the Pfizer BioNTech or AstraZeneca vaccine had antibody levels that were significantly higher than infected individ | |
 | At least 73 per cent population of Odisha has developed antibodies against COVID: ICMR surveyThere was also no difference in developing antibody after taking Covaxin and Covishield vaccines, ICMR's Regional Medical Research director said. | |
 | Antibody that protects against broad range of COVID-19 virus variants discoveredResearchers have discovered an antibody that attaches to a part of the virus that differs little across the variants, meaning that it is unlikely for resistance to arise at this spot | |
 | What The FAQ: What is monoclonal antibody therapy? How is it helpful for COVID patients?In today's FAQ, we try to know what is the monoclonal antibody therapy, how is it done and helpful for COVID-19 patients | |
 | As the Pfizer-BioNTech vaccine becomes available for children over 12, here's what we can expectAdolescents made high levels of antibody in response to the vaccine, and their immune response was just as strong as what has been seen in older teens and young adults 16-25 years of age | |
 | Is Sotrovimab the new treatment for mild COVID cases? European Medicines Agency seeks authorisationSotrovimab is a monoclonal antibody, a lab-produced antibody that is intended to stimulate the immune system by reducing the ability of the coronavirus's spike protein to enter the body's cells | |
 | Common bowel disease treatment may blunt COVID-19 vaccine response: StudyThe study, published in the journal GUT, measured antibody response after vaccination with the Pfizer/BioNTech or the Oxford/AstraZeneca COVID-19 vaccine in 865 people treated with infliximab | |
 | Northwestern University researchers find novel potential therapy for Crohn's disease in childrenAccording to the team, this approach could become an alternative to biologic antibody therapies that carry many side effects, including increased risk of certain cancers. | |
 | VIMSAR doctors to study impact of COVID-19 vaccines and seroconversionSeroconversion is the time period during which a specific antibody develops and becomes detectable in the blood | |
 | US Study finds why some COVID-19 patients may not develop lasting immunityThis process, along with controlled mutations in antibody genes, allows the immune system to select for and immortalise B cells that make the best antibodies against a particular pathogen | |
 | COVID-19 immune response may remain stable for two months after diagnosis, scientists sayScientists from St George's University of London in the UK said antibodies were not detectable in everyone exposed to the virus, opening discussions on how best to interpret antibody and viral tests | |
 | SARS antibody found to neutralise COVID-19 virus that could be the next step towards potential clinical trialsThe antibody, called S309, is now on a fast-track development and testing path at San Francisco-headquartered Vir Biotechnology in the next step toward possible clinical trials | |
 | Researchers develop a fast, sensitive antibody blood test for COVID-19Published in the journal Analytical Chemistry, the study revealed that researchers from China wanted to develop a fast, sensitive antibody test to help identify people with current or past exposure |
Search results 1 - 13 of 103